173 related articles for article (PubMed ID: 30074214)
21. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
Yu JM; Sun W; Hua F; Xie J; Lin H; Zhou DD; Hu ZW
Cancer Lett; 2015 Sep; 365(2):190-200. PubMed ID: 26049022
[TBL] [Abstract][Full Text] [Related]
22. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of SDF-1/CXCR4-induced epithelial-mesenchymal transition by kisspeptin-10.
Gründker C; Bauerschmitz G; Knapp J; Schmidt E; Olbrich T; Emons G
Breast Cancer Res Treat; 2015 Jul; 152(1):41-50. PubMed ID: 26062751
[TBL] [Abstract][Full Text] [Related]
24. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
Jin L; Chen J; Li L; Li C; Chen C; Li S
Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
[TBL] [Abstract][Full Text] [Related]
25. Cyclin D1, Id1 and EMT in breast cancer.
Tobin NP; Sims AH; Lundgren KL; Lehn S; Landberg G
BMC Cancer; 2011 Sep; 11():417. PubMed ID: 21955753
[TBL] [Abstract][Full Text] [Related]
26. Sodium Channel Na
Gradek F; Lopez-Charcas O; Chadet S; Poisson L; Ouldamer L; Goupille C; Jourdan ML; Chevalier S; Moussata D; Besson P; Roger S
Sci Rep; 2019 Dec; 9(1):18652. PubMed ID: 31819138
[TBL] [Abstract][Full Text] [Related]
27. Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.
Olshavsky NA; Comstock CE; Schiewer MJ; Augello MA; Hyslop T; Sette C; Zhang J; Parysek LM; Knudsen KE
Cancer Res; 2010 May; 70(10):3975-84. PubMed ID: 20460515
[TBL] [Abstract][Full Text] [Related]
28. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.
Shi SJ; Wang LJ; Yu B; Li YH; Jin Y; Bai XZ
Oncotarget; 2015 May; 6(13):11652-63. PubMed ID: 25871474
[TBL] [Abstract][Full Text] [Related]
29. MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells.
Li S; Lu J; Chen Y; Xiong N; Li L; Zhang J; Yang H; Wu C; Zeng H; Liu Y
Cell Mol Immunol; 2017 Jul; 14(7):621-630. PubMed ID: 26996066
[TBL] [Abstract][Full Text] [Related]
30. Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events.
Matos ML; Lapyckyj L; Rosso M; Besso MJ; Mencucci MV; Briggiler CI; Giustina S; Furlong LI; Vazquez-Levin MH
J Cell Physiol; 2017 Jun; 232(6):1368-1386. PubMed ID: 27682981
[TBL] [Abstract][Full Text] [Related]
31. αvβ3 Integrin induces partial EMT independent of TGF-β signaling.
Kariya Y; Oyama M; Suzuki T; Kariya Y
Commun Biol; 2021 Apr; 4(1):490. PubMed ID: 33883697
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of RPA2 promotes NF-κB activation in breast cancer by relieving the antagonistic function of menin on NF-κB-regulated transcription.
Chen CC; Juan CW; Chen KY; Chang YC; Lee JC; Chang MC
Carcinogenesis; 2017 Feb; 38(2):196-206. PubMed ID: 28007956
[TBL] [Abstract][Full Text] [Related]
33. Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity.
Mezencev R; Matyunina LV; Jabbari N; McDonald JF
BMC Cancer; 2016 Mar; 16():236. PubMed ID: 26988558
[TBL] [Abstract][Full Text] [Related]
34. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
35. Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling.
Wen S; Hou Y; Fu L; Xi L; Yang D; Zhao M; Qin Y; Sun K; Teng Y; Liu M
Cancer Lett; 2019 Feb; 442():320-332. PubMed ID: 30391782
[TBL] [Abstract][Full Text] [Related]
36. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
[TBL] [Abstract][Full Text] [Related]
37. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
38. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.
Tan CC; Li GX; Tan LD; Du X; Li XQ; He R; Wang QS; Feng YM
Oncotarget; 2016 Nov; 7(48):79688-79705. PubMed ID: 27806311
[TBL] [Abstract][Full Text] [Related]
40. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]